# EDGAR Filing Document

**Accession Number:** 0001760764
**File Stem:** 0001213900-23-012537
**Filing Date:** 2023-2
**Character Count:** 3359
**Document Hash:** 541de14a948b2855a6dbbc3e070fe610
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-012537.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0001213900-23-012537

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230216

**FILED AS OF DATE**: 20230217

**DATE AS OF CHANGE**: 20230216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** G Medical Innovations Holdings Ltd.
- **CENTRAL INDEX KEY:** 0001760764
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39674
- **FILM NUMBER:** 23639961

**BUSINESS ADDRESS:**
- **STREET 1:** 5 OPPENHEIMER ST.
- **CITY:** REHOVOT
- **STATE:** L3
- **ZIP:** 7670105
- **BUSINESS PHONE:** 972-89584777

**MAIL ADDRESS:**
- **STREET 1:** 5 OPPENHEIMER ST.
- **CITY:** REHOVOT
- **STATE:** L3
- **ZIP:** 7670105

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of February 2023

(Report No. 2)

Commission file number: 001-39674

**<u>G MEDICAL INNOVATIONS HOLDINGS LTD.</u>**

(Translation of registrant's name into English)

**5 Oppenheimer St.**

**Rehovot 7670105, Israel**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

**<u>CONTENTS</u>**

***Extraordinary General Meeting of Shareholders***

 ****

On February 16, 2023, the previously adjourned Extraordinary General Meeting of Shareholders (the "Meeting") of G Medical Innovations Holdings Ltd. (the "Company") was convened. At the Meeting, a quorum was present and the shareholders of the Company voted upon and approved all agenda items that were described in the Company's Notice and Proxy Statement for the Meeting, which were included as Exhibit 99.1 to the Company's Report of Foreign Private Issuer on Form 6-K that the Company furnished to the Securities and Exchange Commission on January 24, 2023.

 ****

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company's Registration Statement on <u>[Form F-3](http://www.sec.gov/Archives/edgar/data/1760764/000121390022038574/ea162674-f3_gmedicalinno.htm)</u> (File No. 333-266090) and on <u>[Form S-8](http://www.sec.gov/Archives/edgar/data/1760764/000121390022038235/ea162608-s8_gmedical.htm)</u> (File No. 333-266063), filed with the SEC, to be a part thereof from the date on which this Report is submitted to the extent not superseded by documents or reports subsequently filed or furnished.

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **G Medical Innovations Holdings Ltd.** | **G Medical Innovations Holdings Ltd.** | **G Medical Innovations Holdings Ltd.** |
| Date: February 16, 2023 | By: | /s/ Yacov Geva | /s/ Yacov Geva |
|  |  | Name: | Yacov Geva |
|  |  | Title: | Chief Executive Officer |

---